Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2

Front Cell Infect Microbiol. 2022 Jun 14:12:931061. doi: 10.3389/fcimb.2022.931061. eCollection 2022.

Abstract

Novel coronavirus pneumonia (COVID-19) is spreading worldwide, causing great harm and stress to humans. Since patients with novel coronavirus (SARS-CoV-2) have a high probability of developing acute respiratory distress syndrome (ARDS) in severe cases, the pathways through which SARS-CoV-2 causes lung injury have become a major concern in the scientific field. In this paper, we investigate the relationship between SARS-CoV-2 and lung injury and explore the possible mechanisms of COVID-19 in ARDS from the perspectives of angiotensin-converting enzyme 2 protein, cytokine storm, activation of the immune response, triggering of Fas/FasL signaling pathway to promote apoptosis, JAK/STAT pathway, NF-κB pathway, type I interferon, vitamin D, and explore the possibility of prevention and treatment of COVID-19. To explore the possibility of SARS-CoV-2, and to provide new ideas to stop the development of ARDS in COVID-19 patients.

Keywords: NF-κB pathway; acute respiratory distress syndrome; angiotensin-converting enzyme II protein; cytokine storm; immune response; novel coronavirus; type I interferon.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / complications
  • Humans
  • Janus Kinases
  • Lung Injury*
  • Respiratory Distress Syndrome* / etiology
  • Respiratory Distress Syndrome* / prevention & control
  • SARS-CoV-2
  • STAT Transcription Factors
  • Signal Transduction

Substances

  • STAT Transcription Factors
  • Janus Kinases